Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Shares of Avadel Are Sinking Today

TheMotleyFool

0 0

Shares of Avadel Pharmaceuticals (NASDAQ: AVDL) are down 14% as of 1:29 p.m. EDT today after the Food and Drug Administration said it would need more time than originally thought to review FT218 -- Avadel's candidate to treat narcolepsy.

After accepting a company's approval filing, the FDA provides applicants with a date known as the Prescription Drug User Fee Amendments date -- or PDUFA date. It's intended to give drugmakers insight into the review timeline.

Image source: Getty Images.

Source Fool.com

Like: 0

AVDL

Share